Table 10 Association between additional findings and outcome
From: Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes
Additional findings contraindicative for COVID19 | Outcome | Total N (%) | |||
|---|---|---|---|---|---|
Ordinary N (%) | ICU and alive N (%) | Dead N (%) | |||
Pleural effusion* | No | 264 (60.3%) | 105 (24.0%) | 69 (15.8%) | 438 (100%) |
Yes | 46 (41.4%) | 46 (41.4%) | 19 (17.1%) | 111 (100%) | |
Lymphadenopathy* | No | 252 (61.3%) | 105 (25.5%) | 54 (13.1%) | 411 (100%) |
Yes | 58 (42.0%) | 46 (33.3%) | 34 (24.6%) | 138 (100%) | |
Total | 310 (56.5%) | 151 (27.5%) | 88 (16.0%) | 549 (100%) | |